Intra-day Stock Recommendation [-]
Script Name Time Call No Buy/Sell Enter Between 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [26-07-2021 to 30-07-2021] Don't Tread
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
AXISBANK W-1 Buy 755 768 785++ 748 - SL HIT
LT W-2 Buy 1611 1635 1649++ 1600 - SL HIT
TATAMOTOR W-3 Buy 295 305 310++ 290 - SL HIT
DRREDDY W-4 Buy 5422 5554 5630++ 5400 - SL HIT
INDUSINDBK W-5 Buy 989 1040 1060++ 976 - SL HIT
MGL W-6 Buy 1144 1176 1196++ 1130 - SL HIT
Mainline IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Windlas Biotech Limited IPO Details 04-08-2020 06-08-2020 ₹ 401.54 Cr ₹ 448 - ₹ 460 30 ₹ 13,800 -
Rolex Rings Limited IPO Details 28-07-2020 30-07-2020 ₹ 700 Cr ₹ 960 - 970 15 ₹ 14,550 -
Glenmark Life Sciences Limited IPO Details 27-07-2020 29-07-2020 ₹ 1513.60 Cr ₹ 695-720 20 ₹ 14,400 -
Tatva Chintan Pharma Chem Limited IPO Details 16-07-2021 20-07-2021 ₹ 500 Cr ₹ 1073-1083 13 ₹ 14,079 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Network People Services Technologies Limited IPO Details 28-07-2020 02-08-2020 ₹ 13.70 Cr ₹ 76 - ₹ 80 1600 ₹ 1,28,000 -
Rex Pipes and Cables IPO Details 28-07-2020 02-08-2020 ₹ 6.24 Cr ₹ 26 4000 ₹ 1,04,000 -
Gretex Corporate Services Ltd IPO Details 27-07-2020 30-07-2020 ₹ 5.13 Cr ₹ 170 800 ₹ 1,36,000 -

Aarti Drugs Limited Buy-Back Details

Part of the USD 500 million Aarti Group of Industries, Aarti Drugs Ltd (ADL) was established way back in in 1984.Since its inception, the Company has established a strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. With its manufacturing facilities at Tarapur and Sarigam, the Company manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs.

Over the years, the Company has been able to carve a niche for itself and is looking forward to expand the volumes. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market.
Aarti Drugs Limited Buy-Back Details
Date of Board Meeting for Buyback Proposal 15-03-2019
Date of Buyback Approval 15-03-2019
Date Public Announcement of Buyback 15-03-2019
Buyback Type Tender Offer
Buyback Record Date 29-03-2019
Buyback Opening Date -
Buyback Closing Date -
Buyback Amount ₹ 25.389 Cr
Buyback Number of Share 2,82,100
Buyback Price ₹ 900 Per Share
Face Value ₹ 10
Holding Time 3 Months
- -
Profit acceptance Ratio
Buy 222 Shares at CMP ₹ 653 [2,00,000/900= 222]
Acceptance Ratio 33% 50% 75% 100%
Buy Price ₹ 653 ₹ 653 ₹ 653 ₹ 653
Amount Invested in Buyback ₹ 1,44,966 ₹ 1,44,966 ₹ 1,44,966 ₹ 1,44,966
No. of Shares Buy 222 222 222 222
Earning Per Share ₹ 247 ₹ 247 ₹ 247 ₹ 247
No. of Shares Buy-Back 73 111 167 222
BuyBack Profit ₹ 18095 ₹ 27417 ₹ 41125 ₹ 54834
Profit(%) - % - % - % - %
Aarti Drugs Limited Contact Details
AARTI DRUGS LIMITED, 
Mahendra Industrial Estate, Ground Floor,
Road No 29, Plot No 109-D, 
SION (East), MUMBAI- 400 022.( INDIA)
TEL: ++91 22 2401 9025 (30 LINES)
FAX: ++91 22 2407 3462 / ++91 22 2407 0144
Email ID:- investorrelations@aartidrugs.com
Website :- http://www.aartidrugs.co.in
Registrar of Aarti Drugs Limited
-

0 Response to "Aarti Drugs Limited Buy-Back Details"

Post a Comment